Evidence map›Paper›PMID 25705886›Full record

ArticleThe Journal of clinical investigation2015

Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.

Kate Baker, Sarah L Gordon, Detelina Grozeva, Margriet van Kogelenberg, Nicola Y Roberts, Michael Pike, Edward Blair, Matthew E Hurles, W Kling Chong, Torsten Baldeweg and 4 more

Open access · greenAbstract readCase ReportsComparative StudyVideo-Audio Media
In one paragraph

Article in The Journal of clinical investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Congenital myasthenic syndromes.Orphanet journal of rare diseases · 2019
    Pooled it
  3. Article
  4. Age-Related Characteristics of SYT1-Associated Neurodevelopmental Disorder.Annals of clinical and translational neurology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. c.1103T>C (p.Ile368Th) de novo Variant in Synaptotagmin 1 (International medical case reports journal · 2024
    Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Kate Baker
Sarah L Gordon
Detelina Grozeva
Margriet van Kogelenberg
Nicola Y Roberts
Michael Pike
Edward Blair
Matthew E Hurles
W Kling Chong
Torsten Baldeweg
Manju A Kurian
Stewart G Boyd
Michael A Cousin
F Lucy Raymond
Great Ormond Street Hospital for Children NHS Foundation Trust · GBWellcome Sanger Institute · GB

Funding

Medical Research Council G1002117Medical Research Council G1002276Wellcome Trust 100140Wellcome Trust WT091310Wellcome Trust WT098051
6 · The paper itself

Abstract

Synaptotagmin-1 (SYT1) is a calcium-binding synaptic vesicle protein that is required for both exocytosis and endocytosis. Here, we describe a human condition associated with a rare variant in SYT1. The individual harboring this variant presented with an early onset dyskinetic movement disorder, severe motor delay, and profound cognitive impairment. Structural MRI was normal, but EEG showed extensive neurophysiological disturbances that included the unusual features of low-frequency oscillatory bursts and enhanced paired-pulse depression of visual evoked potentials. Trio analysis of whole-exome sequence identified a de novo SYT1 missense variant (I368T). Expression of rat SYT1 containing the equivalent human variant in WT mouse primary hippocampal cultures revealed that the mutant form of SYT1 correctly localizes to nerve terminals and is expressed at levels that are approximately equal to levels of endogenous WT protein. The presence of the mutant SYT1 slowed synaptic vesicle fusion kinetics, a finding that agrees with the previously demonstrated role for I368 in calcium-dependent membrane penetration. Expression of the I368T variant also altered the kinetics of synaptic vesicle endocytosis. Together, the clinical features, electrophysiological phenotype, and in vitro neuronal phenotype associated with this dominant negative SYT1 mutation highlight presynaptic mechanisms that mediate human motor control and cognitive development.

Indexed as

Mutation, MissensePoint MutationAmino Acid SequenceAnimalsCalciumCells, CulturedChildEndocytosisEvoked Potentials, VisualExocytosisGenes, DominantHippocampusHumansIntellectual DisabilityKineticsMaleCalciumRecombinant Fusion ProteinsSynaptotagmin ISYT1 protein, human

Identifiers

PMID25705886
PMCPMC4396464
OpenAlexW1973694001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.